// App-Quantinova.ai

e21530 : Filgrastim prophylaxis in elderly cancer patients: A French multicenter observational study (TULIP).

Researchers

Presenter

  • Ivan Krakowski

Principal Investigators

  • Delphine Badinand Ep Van Den Bussche

  • Khaled Benabed

  • Daniela Burlacu

  • Stephane Corbinais

  • Rafik Diab

  • Amr El Weshi

  • Elizabeth Fabre

  • Miriam Gardner

  • Maya Hacini

  • Philippe Janoray

  • Nicolas Jovenin

  • Jean-Loup Mouysset

  • Nacera Sakek

  • Kamel Laribi

Medical Centers

  • Centre Alexis Vautrin, Vandoeuvre-Les-Nancy, France

  • CHU La Timone, Marseille, France

  • Hopital Cote De Nacre, Caen, France

  • Centre Hospitalier Henri Mondor d'Aurillac, Aurillac, France

  • C.H. Saint Malo, Saint Malo, France

  • CHI Emile Durkheim Site Epinal, Epinal, France

  • CH du Cotentin Site de Cherbourg, Cherbourg Octeville, France

  • Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Paris, France

  • Hopital Clinique Claude Bernard - Centre, Prive de Radiotherapie, Metz, France, Metz, France

  • CH De Chambery, Chambery, France

  • Centre De Radiotherapie du Parc, Dijon, France

  • Clinique Francois 1er, Saint Dizier, France

  • Polyclinique du Parc Rambot, Aix En Provence, France

  • Hopital Nord Franche Comte Site Le Mittan, Montbeliard, France

  • Department of Hematology, Centre Hospitalier Le Mans, Le Mans, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Filgrastim

Outcome

  • N/A


Study Design

  • Observational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final